Contrast Media Injectors Market

Industry Outlook

The contrast media injectors market is set to reach US$ 959.8 Mn by 2026 from US$ 532.8 Mn in 2017 projecting stable growth at a compounded annual growth rate (CAGR) of 6.8% during the forecast period from 2018 to 2026. Minimal invasive surgeries equipped with contrast media injectors have grabbed prominence in the last 2 decades on account of factors such as increasing number of patients suffering with chronic diseases and rising public health awareness resulting in enhanced preliminary diagnosis.

The advantages associated with contrast media injectors are they provide real time imaging of surgical site and guides the surgeons to conduct safe surgeries of vital organs. The limitations associated with the market growth of contrast media injectors are frequent product recalls and delayed regulatory approvals from healthcare agencies throughout the globe.

Market Synopsis

Injector systems to dominate the product segment on account of rising demand for computed tomography (CT) and magnetic resonance imaging (MRI)

Injector systems are leading the product segment owing to chief factors such as increasing number of outpatients visiting hospitals to perform preliminary diagnosis and steady rise in the number of clinics and research centers housing well-equipped imaging devices such as computed tomography (CT) scans and magnetic resonance imaging (MRI) etc. Technological advancement in the injector systems has drastically reduced human error and provides high accuracy & efficiency. Consumables will be the fastest growing product segment due to availability of diverse range of tubings and syringes at affordable prices and rapid use of imaging devices results in frequent replacement of consumables to alert physicians of potential hazards such as extravasations and air embolism.

Increasing number of patients suffering with cardiovascular diseases to create a positive traction for interventional cardiology market growth

Interventional cardiology holds the largest market in application segment on account of factors such as rising prevalence of cardiac disorders and increasing demand for visually guided minimal invasive cardiac surgeries. According to World Health Organization (WHO) statistics, annually 17.9 million people die from cardiovascular disease throughout the globe. The major factors responsible for this high mortality are ineffective diagnosis and delayed medical intervention. Radiology will foster exemplary growth during the forecast period owing to prime factors such as increasing number of traumatic and non-traumatic cases throughout the globe and increasing demand for preliminary diagnosis to determine disease etiology and associated treatment regimen.

Well-developed healthcare infrastructure to drive the contrast media injectors market in North America

In the current scenario North America is the leader in the contrast media injectors market with 38% share. The key factors that define its dominance are rising prevalence of chronic diseases and well developed healthcare infrastructure. Domicile of key players such as GE Healthcare and VIVID IMAGING cater the requirement of injector systems for interventional cardiology and radiology. Increasing public health awareness resulting in early diagnosis favors contrast media injectors market growth in North America. In Europe the market growth is driven by increased funding in the research and development of consumables pertaining to contrast media injectors. Healthcare institutions heavily rely upon use of CT scan and MRI for the diagnosis of diseases which serves as a lucrative market for the consumables employed in contrast media injector systems. Asia Pacific will register steady growth during the forecast period on account of key factors such as increasing number of traumatic incidents requiring visual guided surgeries and rapid installation of medical imaging equipment in hospitals and clinics.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Inorganic and organic market growth analysis were performed to determine the market assessment. The market segmentation for the scope of report is done as by product, application and geography.

Market assessment is an important tool to understand the existing trends in the contrast media injectors market. Technical innovations pertaining to syringes, injectors, tubing’s etc. are covered in the scope of the report. Merger & acquisition and strategic collaboration among key players are covered by studying the organic and inorganic market growth strategies. The key players manufacturing contrast media injector systems and consumables are APOLLO RT Co., Ltd., Sino Medical-Device Technology Co., Ltd, Bayer Healthcare LLC, GE Healthcare, Guerbet Group, Medtron AG, VIVID IMAGING, Nemoto Kyorindo Co., Ltd., Bracco Group and Ulrich GmbH & Co., KG.

Key questions answered in this report

• Who are the key players providing system injectors and consumables for contrast media injectors market?
• Market assessment and competitive landscape are studied and briefly mentioned in the scope of the report?
• What are the drivers, restraints and opportunities pertaining to the contrast media injectors market?
• Which is the leading and fastest growing product segment in the contrast media injectors market?
• Which is the leading and fastest growing application segment in the contrast media injectors market?
• Which is the leading and fastest growing regional segment in the contrast media injectors market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global CMI Market Portraiture
2.2. Global CMI Market, by Product, 2017 (US$ Mn)
2.3. Global CMI Market, by Application, 2017 (US$ Mn)
2.4. Global CMI Market, by Geography, 2017 (US$ Mn)

Chapter 3. Contrast Media Injectors (CMI) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CMI Market, by Key Players, 2017

Chapter 4. Global Contrast Media Injectors (CMI) Market, by Product
4.1. Overview
4.2. Injector Systems
4.2.1. CT Injector System
4.2.2. MRI Injector System
4.2.3. Cardiovascular/Angiography Injector System
4.3. Consumables

Chapter 5. Global Contrast Media Injectors (CMI)Market, by Application
5.1. Overview
5.2. Interventional Radiology
5.3. Interventional Cardiology
5.4. Radiology

Chapter 6. Global Contrast Media Injectors (CMI) Market, by Geography
6.1. Overview
6.2. North America CMI Market Analysis, 2016 – 2026
6.2.1. North America CMI Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America CMI Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America CMI Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe CMI Market Analysis, 2016 – 2026
6.3.1. Europe CMI Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe CMI Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific CMI Market Analysis, 2016 – 2026
6.4.1. Asia Pacific CMI Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific CMI Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America CMI Market Analysis, 2016 – 2026
6.5.1. Latin America CMI Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America CMI Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa CMI Market Analysis, 2016 – 2026
6.6.1. MEA CMI Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA CMI Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. APOLLO RT Co., Ltd.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bracco Group
7.3. Bayer Healthcare LLC
7.4. GE Healthcare
7.5. Guerbet Group
7.6. Medtron AG
7.7. Nemoto Kyorindo Co., Ltd.
7.8. Sino Medical-Device Technology Co., Ltd.
7.9. Ulrich GmbH & Co. KG
7.10. VIVID IMAGING

List of Figures

FIG. 1 Contrast Media Injectors (CMI) Market: Research Methodology
FIG. 2 CMI Market Segmentation
FIG. 3 Global CMI Market, by Product, 2017 (US$ Mn)
FIG. 4 Global CMI Market, by Application, 2017 (US$ Mn)
FIG. 5 Global CMI Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global CMI Market, by Key Players, 2017
FIG. 8 Global CT Injector System Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 9 Global MRI Injector System Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 10 Global Cardiovascular/Angiography Injector System Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 11 Global Consumables Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 12 Global Interventional Radiology Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 13 Global Interventional Cardiology Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 14 Global Radiology Market for Contrast Media Injectors, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. CMI Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada CMI Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. CMI Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany CMI Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe CMI Market, 2016 – 2026 (US$ Mn)
FIG. 20 China CMI Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan CMI Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific CMI Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil CMI Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico CMI Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America CMI Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC CMI Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA CMI Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Contrast Media Injectors (CMI) Market Portraiture
TABLE 2 Global CMI Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Injector Systems Market for Contrast Media Injectors, by Product, 2016 – 2026 (US$ Mn)
TABLE 4 Global CMI Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 5 Global CMI Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America CMI Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 7 North America CMI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 8 North America CMI Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Europe CMI Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 10 Europe CMI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 11 Europe CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific CMI Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific CMI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America CMI Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America CMI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa CMI Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa CMI Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East and Africa CMI Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 21 APOLLO RT Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bracco Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Bayer Healthcare LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Guerbet Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Medtron AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Nemoto Kyorindo Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Sino Medical-Device Technology Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Ulrich GmbH & Co., KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 VIVID IMAGING: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)